(5-003) Novel Beta-Lactam/Beta-Lactamase Inhibitor Combination Use in Morbidly Obese Patients with Pseudomonas Aeruginosa Pneumonia: Multicenter Evaluation of Clinical and Safety Endpoints
Monday, December 5, 2022
4:15 PM – 5:15 PM
Location: Bayside A, Level 1
Category: Evaluative Study Topic: Infectious Diseases/HIV
Co-Author(s): Ashlan Kunz-Coyne, Kristen Lucas, Michael Rybak, Michael Veve
Primary Author(s)
Carolina Orzol
PharmD. Candidate Wayne State University, Michigan
